Anupam Rasayan India Q3 FY26 results (Oct–Dec 2025) and concall

Chemicals · Concall AI · Call held 14 Feb 2026

Company page: Anupam Rasayan India share price, financials & guidance record

Anupam Rasayan reported strong financial performance for Q3 and 9MFY26, driven by commercial molecule scale-up and improved capacity utilization. The company announced the strategic acquisition of Jayhawk Fine Chemicals, aiming to expand its global footprint and access high-value end markets. Segmental growth was robust, particularly in Pharma and Performance Material, contributing to a diversified revenue mix.

You’re reading a preview. Opening the full call uses 1 concall credit.

What they filed

Q3 FY26: revenue up 31.3%, net profit up 13.0% against the same quarter last year.

₹ Cr · quarterly

Line item	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26
Revenue	294	390	500	486	731 +149%	512 +31%
Expenses	214	266	356	362	596	385
EBITDA	80	124	144	124	136 +70%	127 +2%
Margin	27%	32%	29%	26%	19%	25%
Other income	2	-4	6	5	8	2
Interest	27	32	31	36	36	35
Depreciation	22	29	31	31	32	34
Profit before tax	34	59	88	63	76 +124%	60 +2%
Tax rate	10%	9%	29%	23%	24%	-1%
Net profit	31	54	63	48	57 +84%	61 +13%
EPS	1.52	2.56	4.05	3.10	3.90	4.31

How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.

What they filed

More Chemicals earnings calls